AFL
Aflac IncPrice & Indicators
Blended from price, positioning & fundamentals · daily-close · not investment advice.
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders Strong BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted earnings per diluted share non-GAAP | $7.49 | the full year | — |
| Aflac U.S. sales | $551M | the fourth quarter | — |
| Pretax adjusted profit margin (Japan segment) non-GAAP | 36.7% | the full year | — |
| Pretax adjusted profit margin (U.S. segment) non-GAAP | 20.6% | the full year | — |
| Total new annualized premium sales (Aflac Japan) | 74.4B | the full year | — |
| Total new sales (Aflac U.S.) | $1.6B | the full year | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AFL
this stock
Aflac Inc
|
$61.53B | +10.2% | -9.3% | 13.8 | 2.1% |
|
CILJF
China Life Insurance Co Ltd
|
$100.34B | +2.9% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$68.59B | +14.6% | — | — | 0.8% |
|
MET
Metlife Inc
|
$57.95B | +14.9% | +8.6% | 17.4 | 2.5% |
|
GWLIF
Great-West Lifeco Inc.
|
$57.61B | +31.0% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AFL | +2.2% | +5.6% | +10.2% | +3.1% | +10.2% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +0.8% | +6.8% | +2.2% | +3.4% | +1.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.